BiotechTube

ARQ-151 0.3% cream + ARQ-151 vehicle cream

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Chronic Plaque Psoriasis

Conditions

Chronic Plaque Psoriasis

Trial Timeline

Dec 17, 2019 → Nov 23, 2020

NCT ID
NCT04211389

About ARQ-151 0.3% cream + ARQ-151 vehicle cream

ARQ-151 0.3% cream + ARQ-151 vehicle cream is a phase 3 stage product being developed by Arcutis Biotherapeutics for Chronic Plaque Psoriasis. The current trial status is completed. This product is registered under clinical trial identifier NCT04211389. Target conditions include Chronic Plaque Psoriasis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT04211389Phase 3Completed

Competing Products

20 competing products in Chronic Plaque Psoriasis

See all competitors
ProductCompanyStageHype Score
macitentan 10 mgBML, Inc.Phase 3
76
KPL-716 + PlaceboKiniksa PharmaceuticalsPhase 2
47
TERN-701Terns PharmaceuticalsPhase 1/2
38
Fludarabine + Cyclophosphamide + PRGN-3007PrecigenPhase 1
28
LY3556050 + PlaceboEli LillyPhase 2
52
THB001Third Harmonic BioPhase 1
25
BriquilimabJasper TherapeuticsPhase 1/2
33
BriquilimabJasper TherapeuticsPhase 1/2
33
BriquilimabJasper TherapeuticsPhase 2
44
Empagliflozin + Matching placeboEli LillyPhase 3
77
LY3461767 + PlaceboEli LillyPhase 1
33
Pirtobrutinib + Venetoclax + RituximabEli LillyPhase 3
77
LY3526318 + PlaceboEli LillyPhase 2
52
PirtobrutinibEli LillyPhase 2
52
Ibrutinib + LY3214996Eli LillyPhase 1
33
Pirtobrutinib + AcalabrutinibEli LillyPhase 2
52
LYR-210Lyra TherapeuticsPhase 2
44
LYR-220 Design 1 (Part 1 only) + LYR-220 Design 2 (Part 1 and Part 2) + Bilateral sham procedure control (Part 2)Lyra TherapeuticsPhase 2
44
480 Mometasone Furoate Sinus Drug DepotLyra TherapeuticsPhase 1
25
LYR-210 + Sham procedure controlLyra TherapeuticsPhase 3
69

Other Products from Arcutis Biotherapeutics

ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%Phase 3
72
Roflumilast Cream + Vehicle creamPhase 3
72
Roflumilast Foam 0.3% + Vehicle FoamPhase 3
72
Roflumilast Foam + Vehicle FoamPhase 3
72
Roflumilast Cream 0.05% + Vehicle CreamPhase 3
72